Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer

Global cancer statistics

Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,708 · see citing works

The basics of epithelial-mesenchymal transition

Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · see citing works

Epithelial-Mesenchymal Transitions in Development and Disease

Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · see citing works

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,679 · see citing works

Epithelial–mesenchymal transitions in tumour progression

Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,632 · see citing works

Cancer Metastasis: Building a Framework

Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,230 · see citing works

Complex networks orchestrate epithelial–mesenchymal transitions

Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,947 · see citing works

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · see citing works

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206 · see citing works

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124 · see citing works

Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis

Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,005 · see citing works

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545 · see citing works

The epithelial–mesenchymal transition: new insights in signaling, development, and disease

Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,011 · see citing works

A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cells

Burk, U., Schubert, J., Wellner, U. F., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO Reports · doi:10.1038/embor.2008.74 · Cited by 1,722 · see citing works

Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

Morel, A., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,673 · see citing works

Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · see citing works

AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective

Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,172 · see citing works

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

Kudo‐Saito, C., Shirako, H., Takeuchi, T., & Kawakami, Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.023 · Cited by 872 · see citing works

The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?

Brabletz, S., & Brabletz, T. (2010) · EMBO Reports · doi:10.1038/embor.2010.117 · Cited by 793 · see citing works

Epithelial–mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic

Voulgari, A., & Pintzas, A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.002 · Cited by 673 · see citing works

Carcinoma Invasion and Metastasis: A Role for Epithelial-Mesenchymal Transition?

Thompson, E. W., & Newgreen, D. F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0616 · Cited by 667 · see citing works

Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition

Thomson, S., Buck, E. A., Petti, F., Griffin, G., Brown, E., Ramnarine, N., Iwata, K. K., Gibson, N. W., & Haley, J. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1058 · Cited by 663 · see citing works

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations

Yano, S., Wang, W., Li, Q., Matsumoto, K., Sakurama, H., Nakamura, T., Ogino, H., Kakiuchi, S., Hanibuchi, M., Nishioka, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1643 · Cited by 643 · see citing works

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Ohe, Y., Ohashi, Y., Kubota, K., Tamura, T., Nakagawa, K., Negoro, S., Nishiwaki, Y., Saijo, N., Ariyoshi, Y., & Fukuoka, M. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl377 · Cited by 633 · see citing works

Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

Yang, M., Hsu, D. S., Wang, H., Wang, H.-J., Lan, H., Yang, W., Huang, C.-H., Kao, S., Tzeng, C., Tai, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2099 · Cited by 631 · see citing works

The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Brabletz, T., Strand, D., Obrist, P., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210508 · Cited by 618 · see citing works

Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer

Mitsudomi, T., & Yatabe, Y. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00607.x · Cited by 606 · see citing works

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expressionPreprint

Gibbons, D. L., Lin, W., Creighton, C. J., Rizvi, Z. H., Gregory, P. A., Goodall, G. J., Thilaganathan, N., Du, L., Zhang, Y., Pertsemlidis, A., et al. (2009) · Genes & Development · doi:10.1101/gad.1820209 · Cited by 516 · see citing works

Epithelial versus Mesenchymal Phenotype Determines <i>In vitro</i> Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients

Yauch, R. L., Januario, T., Eberhard, D. A., Cavet, G., Zhu, W., Fu, L., Pham, T. Q., Soriano, R., Stinson, J., Seshagiri, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1492 · Cited by 495 · see citing works

Epithelial-mesenchymal transition

Radisky, D. C. (2005) · Journal of Cell Science · doi:10.1242/jcs.02552 · Cited by 414 · see citing works

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells

Song, L.-B., Li, J., Liao, W., Feng, Y., Yu, C.-P., Hu, L.-J., Kong, Q., Xu, L.-H., Zhang, X., Liu, W.-L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39374 · Cited by 395 · see citing works

The EMT regulator slug and lung carcinogenesis

Shih, J.-Y., & Yang, P. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr110 · Cited by 315 · see citing works

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors

Bonde, A.-K., Tischler, V., Kumar, S., Soltermann, A., & Schwendener, R. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-35 · Cited by 284 · see citing works

Epithelial-Mesenchymal Transition Events during Human Embryonic Stem Cell Differentiation

Eastham, A. M., Spencer, H., Soncin, F., Ritson, S., Merry, C. L. R., Stern, P. L., & Ward, C. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2253 · Cited by 280 · see citing works

EMT and Stem Cell–Like Properties Associated with miR-205 and miR-200 Epigenetic Silencing Are Early Manifestations during Carcinogen-Induced Transformation of Human Lung Epithelial Cells

Tellez, C. S., Juri, D. E., Do, K., Bernauer, A. M., Thomas, C. L., Damiani, L. A., Tessema, M., Leng, S., & Belinsky, S. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3035 · Cited by 277 · see citing works

Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer

Soltermann, A., Tischler, V., Arbogast, S., Braun, J., Probst-Hensch, N. M., Weder, W., Moch, H., & Kristiansen, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0935 · Cited by 269 · see citing works

Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells

Battula, V. L., Evans, K. W., Hollier, B. G., Shi, Y., Marini, F. C., Ayyanan, A., Wang, R., Brisken, C., Guerra, R., Andreeff, M., et al. (2010) · Stem Cells · doi:10.1002/stem.467 · Cited by 266 · see citing works

Epithelial-Mesenchymal Transition in Cervical Cancer: Correlation with Tumor Progression, Epidermal Growth Factor Receptor Overexpression, and Snail Up-Regulation

Lee, M.-Y., Chou, C.-Y., Tang, M., & Shen, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0234 · Cited by 255 · see citing works

Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer

Guo, B., Feng, Y., Zhang, R., Xu, L.-H., Li, M.-Z., Kung, H., Song, L.-B., & Zeng, M. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-10 · Cited by 225 · see citing works

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

Rho, J. K., Choi, Y. J., Lee, J. K., Ryoo, B., Na, I. I., Yang, S. H., Kim, C. H., & Lee, J. C. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.05.017 · Cited by 220 · see citing works

Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations

Floor, S. L., van Staveren, W. C. G., Larsimont, D., Dumont, J. E., & Maenhaut, C. (2011) · Oncogene · doi:10.1038/onc.2011.184 · Cited by 204 · see citing works

Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions

Barr, S. M., Thomson, S., Buck, E. A., Russo, S. M., Petti, F., Sujka-Kwok, I., Eyzaguirre, A., Rosenfeld-Franklin, M., Gibson, N. W., Miglarese, M. R., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9121-7 · Cited by 197 · see citing works

Epithelial mesenchymal transition and lung cancer.

Xiao, D., & He, J. (2010) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2010.02.03.7 · Cited by 193 · see citing works

Activation of notch‐1 enhances epithelial–mesenchymal transition in gefitinib‐acquired resistant lung cancer cells

Xie, M., Zhang, L., He, C., Xu, F., Liu, J., Hu, Z., Zhao, L., & Tian, Y. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24019 · Cited by 191 · see citing works

ZEB1 Enhances Transendothelial Migration and Represses the Epithelial Phenotype of Prostate Cancer Cells

Drake, J. M., Strohbehn, G. W., Bair, T., Moreland, J. G., & Henry, M. D. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-10-1076 · Cited by 177 · see citing works

Epithelial to Mesenchymal Transition by TGFβ-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line

Pirozzi, G., Tirino, V., Camerlingo, R., Franco, R., Rocca, A. L., Liguori, E., Martucci, N., Paino, F., Normanno, N., & Rocco, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021548 · Cited by 172 · see citing works

Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction

Baritaki, S., Chapman, A. M., Yeung, K. C., Spandidos, D. A., Palladino, M. A., & Bonavida, B. (2009) · Oncogene · doi:10.1038/onc.2009.214 · Cited by 168 · see citing works

Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma.

Uramoto, H., Iwata, T., Onitsuka, T., Shimokawa, H., Hanagiri, T., & Oyama, T. (2010) · PubMed · Cited by 168 · see citing works

FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers

Tang, Y.-N., Shu, G., Yuan, X., Jing, N., & Song, J. (2010) · Cell Research · doi:10.1038/cr.2010.126 · Cited by 160 · see citing works

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Metastatic to the Brain

Jamal‐Hanjani, M., & Spicer, J. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2529 · Cited by 146 · see citing works

Prognostic importance of epithelial–mesenchymal transition‐related protein expression in gastric carcinoma

Kim, M. A., Lee, H. S., Lee, H. E., Kim, J., Yang, H., & Kim, W. H. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03247.x · Cited by 140 · see citing works

Peroxisome Proliferator-Activated Receptor-γ Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition

Reka, A. K., Kurapati, H., Narala, V. R., Bommer, G. T., Chen, J., Standiford, T. J., & Keshamouni, V. G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0570 · Cited by 136 · see citing works

Advances in Target Therapy for Lung Cancer

Mitsudomi, T. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp174 · Cited by 84 · see citing works

EMT and MET in carcinoma—clinical observations, regulatory pathways and new models

Thompson, E. W., & Williams, E. D. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9189-8 · Cited by 69 · see citing works

Epithelial–Mesenchymal Transition in Lung Cancer

Dasari, V. K., Gallup, M., Lemjabbar, H., Maltseva, I., & McNamara, N. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0051sf · Cited by 62 · see citing works

Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model

Argast, G. M., Krueger, J. S., Thomson, S., Sujka-Kwok, I., Carey, K., Silva, S., O’Connor, M., Mercado, P., Mulford, I. J., Young, G. D., et al. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9394-8 · Cited by 61 · see citing works

Expression of the ZEB1 (δEF1) transcription factor in human: additional insights

Hurt, E. M., Saykally, J. N., Anose, B. M., Kalli, K. R., & Sanders, M. M. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9860-z · Cited by 55 · see citing works

Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial–mesenchymal transition in pancreatic cancer

Ding, Q., Yoshimitsu, M., Kuwahata, T., Maeda, K., Hayashi, T., Obara, T., Miyazaki, Y., Matsubara, S., Natsugoe, S., & Takao, S. (2011) · Human Cell · doi:10.1007/s13577-011-0037-9 · Cited by 49 · see citing works

The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung adenocarcinoma.

Chikaishi, Y., Uramoto, H., & Tanaka, F. (2011) · PubMed · Cited by 28 · see citing works

The relationship between Bmi-1 and the epithelial–mesenchymal transition in lung squamous cell carcinoma

Huang, J., Qiu, Y., Chen, G., Huang, L., & He, J. (2011) · Medical Oncology · doi:10.1007/s12032-011-9998-5 · Cited by 20 · see citing works

EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer

Giaccone, G. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0200 · Cited by 20 · see citing works

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

Wu, S., & Shih, J. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0777-1 · Cited by 789 · see citing works

Challenges and Opportunities in Cancer Drug Resistance

Ward, R. A., Fawell, S. E., Floc’h, N., Flemington, V., McKerrecher, D., & Smith, P. D. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00383 · Cited by 454 · see citing works

Drug resistance in cancer: mechanisms and tackling strategies

Haider, T., Pandey, V., Banjare, N., Gupta, P. N., & Soni, V. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00138-7 · Cited by 312 · see citing works

Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy

Nagano, T., TACHIHARA, M. Y., & Nishimura, Y. (2018) · Cells · doi:10.3390/cells7110212 · Cited by 252 · see citing works

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

de Castro, D. G., Clarke, P. A., Al‐Lazikani, B., & Workman, P. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.237 · Cited by 234 · see citing works

Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

Jin, H., He, Y., Zhao, P., Hu, Y., Tao, J., Chen, J., & Huang, Y. (2018) · Theranostics · doi:10.7150/thno.27246 · Cited by 220 · see citing works

Precision Management of Advanced Non–Small Cell Lung Cancer

Yang, C., Yang, J. C., & Yang, P. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-051718-013524 · Cited by 207 · see citing works

EGFR-TKI resistance in NSCLC patients: mechanisms and strategies.

Lin, Y., Wang, X., & Jin, H. (2014) · Europe PMC (PubMed Central) · Cited by 198 · see citing works

Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting

Rimal, R., Desai, P. B., Daware, R., Hosseinnejad, A., Prakash, J., Lammers, T., & Singh, S. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114504 · Cited by 201 · see citing works

Cytoskeletal dynamics in epithelial-mesenchymal transition: insights into therapeutic targets for cancer metastasis

Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., et al. (2021) · Cancers · doi:10.3390/cancers13081882 · Cited by 184 · see citing works

Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner

Kim, S.-H., Ezhilarasan, R., Phillips, E. S., Gallego‐Perez, D., Sparks, A. E., Taylor, D., Ladner, K. J., Furuta, T., Sabit, H., Chhipa, R. R., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.01.005 · Cited by 155 · see citing works

Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells

Han, M., Zhao, Y., Tan, C., Xiong, Y., Wang, W., Wu, F. Y., Yao, F., Wang, L., & Liang, Z. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.93 · Cited by 150 · see citing works

Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids

Ye, Q., Liu, K., Shen, Q., Li, Q., Hao, J., Han, F., & Jiang, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00487 · Cited by 150 · see citing works

SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma

Luanpitpong, S., Li, J., Manke, A., Brundage, K. M., Ellis, E., McLaughlin, S. L., Angsutararux, P., Chanthra, N., Voronkova, M. A., Chen, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.351 · Cited by 118 · see citing works

Tumor Clonality and Resistance Mechanisms in EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Implications for Therapeutic Sequencing

Kohsaka, S., Petronczki, M. P., Solca, F., & Maemondo, M. (2018) · Future Oncology · doi:10.2217/fon-2018-0736 · Cited by 116 · see citing works

Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells

Shi, J., Liu, F., ZHANG, W., Liu, X., Lin, B., & Tang, X. (2015) · Oncology Reports · doi:10.3892/or.2015.3889 · Cited by 117 · see citing works

TGFβ pathway inhibition in the treatment of non-small cell lung cancer

Eser, P. Ö., & Janne, P. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.004 · Cited by 116 · see citing works

Surfactant-based drug delivery systems for treating drug-resistant lung cancer

Kaur, P., Garg, T., Rath, G., Murthy, R. S. R., & Goyal, A. K. (2014) · Drug Delivery · doi:10.3109/10717544.2014.935530 · Cited by 105 · see citing works

Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.

Nakano, I., Garnier, D., Minata, M., & Rak, J. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.02.011 · Cited by 104 · see citing works

Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid

Baronzio, G., Parmar, G., & Baronzio, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00165 · Cited by 100 · see citing works

YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway

Zhao, Y., Khanal, P., Savage, P. B., She, Y., Cyr, T. D., & Yang, X. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2712 · Cited by 95 · see citing works

Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches

Ghosh, S., Javia, A., Shetty, S. R., Bardoliwala, D., Maiti, K., Banerjee, S., Khopade, A. J., Misra, A. R., Sawant, K. K., & Bhowmick, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.014 · Cited by 94 · see citing works

LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers

Chen, C., Liu, W.-R., Zhang, B., Zhang, L.-M., Li, C., Liu, C., Zhang, H., Huo, Y., Ma, Y.-C., Tian, P., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.009 · Cited by 90 · see citing works

Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline

Goffin, J. R., & Zbuk, K. M. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.08.007 · Cited by 87 · see citing works

Stem cell-like ALDH bright cellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin

Corominas-Faja, B., Oliveras‐Ferraros, C., Cuyàs, E., Segura‐Carretero, A., Joven, J., Martı́n-Castillo, B., Barrajón‐Catalán, E., Micol, V., Bosch‐Barrera, J., & Menéndez, J. A. (2013) · Cell Cycle · doi:10.4161/cc.26417 · Cited by 79 · see citing works

Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo

Cufí, S., Bonavia, R., Vázquez‐Martín, A., Oliveras‐Ferraros, C., Corominas-Faja, B., Cuyàs, E., Martı́n-Castillo, B., Barrajón‐Catalán, E., Visa, J., Segura‐Carretero, A., et al. (2013) · Scientific Reports · doi:10.1038/srep02459 · Cited by 78 · see citing works

Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition

Ko, J., Nam, D., Um, J., Jung, S. Y., Sethi, G., & Ahn, K. S. (2018) · Molecules · doi:10.3390/molecules23071601 · Cited by 76 · see citing works

Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells

Pithi Chanvorachote, B., & Luanpitpong, S. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00322.2015 · Cited by 76 · see citing works

Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors

Hahne, J. C., & Valeri, N. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00226 · Cited by 73 · see citing works

Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma

Wangari‐Talbot, J., & Hopper-Borge, E. A. (2013) · Journal of cancer research updates · doi:10.6000/1929-2279.2013.02.04.5 · Cited by 73 · see citing works

Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells

Shah, P. P., Lockwood, W. W., Saurabh, K., Kurlawala, Z., Shannon, S. P., Waigel, S. J., Zacharias, W., & Beverly, L. J. (2014) · Oncogene · doi:10.1038/onc.2014.97 · Cited by 72 · see citing works

Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives

Tang, J., Salama, R., Gadgeel, S. M., Sarkar, F. H., & Ahmad, A. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00015 · Cited by 71 · see citing works

DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties

Little, A. C., Sham, D., Hristova, M., Danyal, K., Heppner, D. E., Bauer, R., Sipsey, L., Habibovic, A., & van der Vliet, A. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.61 · Cited by 70 · see citing works

Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib

Hirsh, V. (2015) · BioDrugs · doi:10.1007/s40259-015-0130-9 · Cited by 68 · see citing works

Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis

Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 66 · see citing works

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis

Xu, J., Yue, C.-F., Zhou, W.-H., Qian, Y., Zhang, Y., Wang, S.-W., Liu, A.-W., & Liu, Q. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-200 · Cited by 66 · see citing works

Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells

Cufí, S., Bonavia, R., Vázquez‐Martín, A., Corominas-Faja, B., Oliveras‐Ferraros, C., Cuyàs, E., Martı́n-Castillo, B., Barrajón‐Catalán, E., Visa, J., Segura‐Carretero, A., et al. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.063 · Cited by 66 · see citing works

Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer

Hu, Y., Dai, M., Zheng, Y., Wu, J., Yu, B., Zhang, H., Kong, W., Wu, H., & Yu, X. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0592-y · Cited by 65 · see citing works

AEG-1 3′-untranslated region functions as a ceRNA in inducing epithelial–mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity

Liu, K., Guo, L., Guo, Y., Zhou, B., Li, T., Yang, H., Yin, R., & Xi, T. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.10.006 · Cited by 61 · see citing works

Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition

Lou, W., Chen, Y., Zhu, K., Deng, H., Wu, T., & Wang, J. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00271 · Cited by 61 · see citing works

Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology

Workman, P., Al‐Lazikani, B., & Clarke, P. A. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.06.004 · Cited by 58 · see citing works

SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial–mesenchymal transition via ERK and PI3K/AKT pathway

Peng, Y., Wang, G., Huo, H., Li, Q., Zhao, Y., & Liu, Y. (2014) · Medical Oncology · doi:10.1007/s12032-014-0377-x · Cited by 57 · see citing works

Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells

Hsieh, Y., Chu, S., Hsu, L., Chen, K.-S., Lai, M., Yeh, C.-H., & Chen, P. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.10.021 · Cited by 55 · see citing works

MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells

Wang, M., Zhang, R., Zhang, S., Xu, R., & Yang, Q. (2019) · Gene · doi:10.1016/j.gene.2019.03.043 · Cited by 54 · see citing works

Growth Hormone and the Epithelial-to-Mesenchymal Transition

Brittain, A. L., Basu, R., Qian, Y., & Kopchick, J. J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01000 · Cited by 54 · see citing works

Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification

Monica, S. L., Caffarra, C., Saccani, F., Galvani, E., Galetti, M., Fumarola, C., Bonelli, M. A., Cavazzoni, A., Cretella, D., Sirangelo, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078656 · Cited by 50 · see citing works

Triclosan Potentiates Epithelial-To-Mesenchymal Transition in Anoikis-Resistant Human Lung Cancer Cells

Winitthana, T., Lawanprasert, S., & Pithi Chanvorachote, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110851 · Cited by 49 · see citing works

Expression of HMGA 2 in bladder cancer and its association with epithelial‐to‐mesenchymal transition

Ding, X., Wang, Y., Ma, X., Guo, H., Xu, Y., Chi, Q., Li, J., Hou, Y., & Wang, C. (2014) · Cell Proliferation · doi:10.1111/cpr.12096 · Cited by 49 · see citing works

Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR

Villemin, J., Bassaganyas, L., Pourquier, D., Boissière, F., Cabello-Aguilar, S., Crapez, E., Tanos, R., Cornillot, E., Turtoi, A., & Colinge, J. (2022) · bioRxiv · doi:10.1093/nar/gkad352 · Cited by 47 · see citing works

Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective

Gao, X., Cai, Y., Wang, Z., He, W., Cao, S., Xu, R., & Chen, H. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2056-3 · Cited by 47 · see citing works

Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells

Busaranon, K., Phiboonchaiyanan, P. P., Sritularak, B., & Pithi Chanvorachote, B. (2015) · Journal of Natural Medicines · doi:10.1007/s11418-015-0931-7 · Cited by 46 · see citing works

ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway

Zhu, X., Guo, X., Wu, S., & Li, W. (2016) · Lung · doi:10.1007/s00408-016-9895-y · Cited by 46 · see citing works

Gigantol Inhibits Epithelial to Mesenchymal Process in Human Lung Cancer Cells

Unahabhokha, T., Pithi Chanvorachote, B., Sritularak, B., Kitsongsermthon, J., & Pongrakhananon, V. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/4561674 · Cited by 46 · see citing works

A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial–mesenchymal transition

Zhao, Y., Han, M., Xiong, Y., Wang, L., Fei, Y., Shen, X., Zhu, Y., & Liang, Z. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.164 · Cited by 46 · see citing works

Lung cancer stem cells: a biological and clinical perspective

Koren, A., Motaln, H., & Čufer, T. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0141-9 · Cited by 44 · see citing works

Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse

Ryu, J., Koh, Y., Park, H., Kim, D. Y., Kim, D. C., Byun, J. M., Lee, H. J., & Yoon, S. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0210 · Cited by 44 · see citing works

FOXC2 promotes epithelial–mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells

He, Y., Xie, H., Yu, P. Y., Jiang, S., & Wei, L. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3697-2 · Cited by 43 · see citing works

Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival

Tarullo, S. E., Hill, R. C., Hansen, K. C., Behbod, F., Borges, V. F., Nelson, A., & Lyons, T. R. (2020) · Oncogene · doi:10.1038/s41388-020-1192-9 · Cited by 42 · see citing works

Fucoidan increased the sensitivity to gefitinib in lung cancer cells correlates with reduction of TGFβ-mediated Slug expression

Qiu, W.-L., Tseng, A.-J., Hsu, H.-Y., Hsu, W.-H., Lin, Z., Hua, W.-J., & Lin, T. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.066 · Cited by 42 · see citing works

Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance

Ghazani, A. A., Pectasides, M., Sharma, A., Castro, C. M., Mino-Kenudson, M. A., Lee, H., Shepard, J.-A. O., & Weissleder, R. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.10.008 · Cited by 39 · see citing works

PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma

Ma, H., Hockla, A., Mehner, C., Coban, M., Papo, N., Radisky, D. C., & Radisky, E. S. (2019) · Scientific Reports · doi:10.1038/s41598-018-38362-0 · Cited by 39 · see citing works

CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma

Maity, G., Ghosh, A., Gupta, V. G., Haque, I., Sarkar, S., Das, A. K., Dhar, K., Bhavanasi, S., Gunewardena, S., Hoff, D. D. V., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0899 · Cited by 38 · see citing works

The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells

Unahabhokha, T., Pithi Chanvorachote, B., & Pongrakhananon, V. (2016) · Tumor Biology · doi:10.1007/s13277-015-4717-z · Cited by 38 · see citing works

Prognostic value of epithelial‐mesenchymal transition‐inducing transcription factors in head and neck squamous cell carcinoma: A meta‐analysis

Wan, Y., Liu, H., Zhang, M., Huang, Z., Zhou, H., Zhu, Y., Tao, Y., Xie, N., Liu, X., Hou, J., et al. (2020) · Head & Neck · doi:10.1002/hed.26104 · Cited by 37 · see citing works

Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I

Upadhya, A., Yadav, K. S., & Misra, A. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1825377 · Cited by 37 · see citing works

Quercetin Inhibits the Epithelial to Mesenchymal Transition through Suppressing Akt Mediated Nuclear Translocation of β-Catenin in Lung Cancer Cell Line

Perumal, E., Ezhilarasan, D., & Subramanian, R. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1957487 · Cited by 37 · see citing works

Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer

Zhang, K., Wang, K., Zhang, X., Qian, Z., Zhang, W., Zheng, X., Wang, J., Jiang, Y., Zhang, W., Lu, Z., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00077 · Cited by 37 · see citing works

Benzo(a)pyrene enhances the EMT-associated migration of lung adenocarcinoma A549 cells by upregulating Twist1

Chen, X., Peng, H., Xiao, J., Guan, A., Xie, B., He, B., & Chen, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.5874 · Cited by 36 · see citing works

A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cells

Hlosrichok, A., Sumkhemthong, S., Sritularak, B., Pithi Chanvorachote, B., & Chaotham, C. (2018) · Journal of Natural Medicines · doi:10.1007/s11418-018-1186-x · Cited by 36 · see citing works

Design, Synthesis and Biological Evaluation of New Pyrimidine Derivatives as Anticancer Agents

Madia, V. N., Nicolai, A., Messore, A., Leo, A. D., Ialongo, D., Tudino, V., Saccoliti, F., Vita, D. D., Scipione, L., Artico, M., et al. (2021) · Molecules · doi:10.3390/molecules26030771 · Cited by 36 · see citing works

Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival

Lu, Y. W., GUAN, G.-F., Chen, J., Hu, B., Sun, C., Ma, Q., Wen, Y., Qiu, X., & Zhou, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3535 · Cited by 36 · see citing works

Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment

Ni, Y., Bi, J., Ye, X., Fan, W., Yu, G., Yang, X., Huang, G., Li, W., Wang, J., Han, X., et al. (2016) · Medicine · doi:10.1097/md.0000000000003998 · Cited by 35 · see citing works

Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance

Xue, Y., Hou, S., Ji, H., & Han, X. (2016) · Protein & Cell · doi:10.1007/s13238-016-0330-1 · Cited by 35 · see citing works

Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition

Fei-Fei, F. E. N. G., CHENG, P., Sun, C., Wang, H., & Wang, W. (2019) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(19)30093-7 · Cited by 35 · see citing works

Menadione (Vitamin K3) Induces Apoptosis of Human Oral Cancer Cells and Reduces their Metastatic Potential by Modulating the Expression of Epithelial to Mesenchymal Transition Markers and Inhibiting Migration

Suresh, S., Raghu, D., & Karunagaran, D. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5461 · Cited by 35 · see citing works

Quercetin and Nano-Derivatives: Potential and Challenges in Cancer Therapy

Li, X., Qi, L., Zhang, X., Wei, C., Yu, B., & Pei, T.-L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s509877 · Cited by 34 · see citing works

Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression

Ko, Y. S., Cho, S. J., Park, J., Kim, Y.-H., Choi, Y. J., Pyo, J., Jang, B. G., Park, J., Kim, W. H., & Lee, B. L. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.273 · Cited by 33 · see citing works

Preliminary mechanisms of regulating PD‑L1 expression in non‑small cell lung cancer during the EMT process

Li, F., Zhu, T., Yue, Y., Zhu, X., Wang, J., & Liang, L. (2018) · Oncology Reports · doi:10.3892/or.2018.6474 · Cited by 33 · see citing works

Overcoming AZD9291 Resistance and Metastasis of NSCLC via Ferroptosis and Multitarget Interference by Nanocatalytic Sensitizer Plus AHP‐DRI‐12

Wang, L., Fu, H., Song, L., Wu, Z., Yu, J., Guo, Q., Chen, C., Yang, X., Zhang, J., Wang, Q., et al. (2022) · Small · doi:10.1002/smll.202204133 · Cited by 32 · see citing works

DRMref: comprehensive reference map of drug resistance mechanisms in human cancer

Liu, X., Yi, J., Li, T., Wen, J., Huang, K., Liu, J., Wang, G., Kim, P., Song, Q., & Zhou, X. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1087 · Cited by 31 · see citing works

Roles and Regulation of Growth differentiation factor-15 in the Immune and tumor microenvironment

Lodi, R. S., Yu, B., Xia, L., & Liu, F. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.06.007 · Cited by 32 · see citing works

Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma

Hwang, H. S., Go, H., Park, J.-M., Yoon, S. Y., Lee, J., Jeong, S. U., & Cho, Y. M. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0188-y · Cited by 32 · see citing works

Endothelial Transdifferentiation of Tumor Cells Triggered by the Twist1‐Jagged1‐KLF4 Axis: Relationship between Cancer Stemness and Angiogenesis

Chen, H., & Wu, K. (2015) · Stem Cells International · doi:10.1155/2016/6439864 · Cited by 31 · see citing works

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition

Tiran, V., Lindenmann, J., Brčić, L., Heitzer, E., Stanzer, S., Ghaffari‐Tabrizi‐Wizsy, N., Stacher, E., Stoeger, H., Popper, H., Balić, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09929-0 · Cited by 31 · see citing works

Clusterin modulates transdifferentiation of non-small-cell lung cancer

Jin, R., Chen, X., Han, D., Luo, X., & Li, H. (2017) · BMC Cancer · doi:10.1186/s12885-017-3649-y · Cited by 31 · see citing works

Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance

Yamazaki, S., Su, Y., Maruyama, A., Makinoshima, H., Suzuki, J., Tsuboi, M., Goto, K., Ochiai, A., & Ishii, G. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.067 · Cited by 31 · see citing works

Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition

Phiboonchaiyanan, P. P., Busaranon, K., Ninsontia, C., & Pithi Chanvorachote, B. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9368-3 · Cited by 31 · see citing works

SPARC acts as a mediator of TGF‐β1 in promoting epithelial‐to‐mesenchymal transition in A549 and H1299 lung cancer cells

Sun, W., Feng, J., Yi, Q., Xu, X., Chen, Y., & Tang, L. (2018) · BioFactors · doi:10.1002/biof.1442 · Cited by 30 · see citing works

GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids

Gallardo‐Pérez, J. C., Rivero-Segura, N. A., Marín‐Hernández, Á., Moreno‐Sánchez, R., & Rodríguez‐Enríquez, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.013 · Cited by 30 · see citing works

Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition

Gomez-Casal, R., Epperly, M. W., Wang, H., Proia, D. A., Greenberger, J. S., & Levina, V. V. (2015) · Oncotarget · doi:10.18632/oncotarget.6248 · Cited by 29 · see citing works

Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition

Duan, Q., Pang, C., Chang, N., Zhang, J., & Liu, W. (2016) · Oncology Reports · doi:10.3892/or.2016.4780 · Cited by 29 · see citing works

Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway

Wang, W.-P., Sun, Y., Lü, Q., Zhao, J., Wang, X., Chen, Z., Ni, Y., Wang, J.-Z., Han, Y., Zhang, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13947 · Cited by 28 · see citing works

Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway

Lou, J., Lan, Y., Gao, J., Ma, B., Yang, T., Yuan, Z., Zhang, H., Zhu, T., Pan, N., Leng, S., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00420 · Cited by 28 · see citing works

Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer

Beck, T. N., Chikwem, A. J., Solanki-Patel, N., & Golemis, E. A. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00062.2014 · Cited by 26 · see citing works

miR-124 modulates gefitinib resistance through SNAI2 and STAT3 in non-small cell lung cancer

Hu, F., Cao, X., Xu, Q., Deng, Y., Lai, S., Ma, J., & Hu, J. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1672-x · Cited by 26 · see citing works

Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.

Sung, W. J., Park, K.-S., Kwak, C. H., Hyun, D.-S., Jang, J. S., & Park, K. (2015) · PubMed Central · Cited by 25 · see citing works

BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer

Shu, J., Wang, L., Han, F., Chen, Y., Wang, S., & Luo, F. (2019) · BioMed Research International · doi:10.1155/2019/5937635 · Cited by 25 · see citing works

MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme

Pan, C., Chan, K.-H., Chen, C., Jan, C.-I., Liu, M.-C., Lin, C., Cho, D., Tsai, W.-C., Chu, Y.-T., Cheng, C., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.024 · Cited by 25 · see citing works

Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells Ontumor Growth and Progression

Rahmatizadeh, F., Aziz, S. G., Khodadadi, K., Ataei, M. L., Ebrahimie, E., Rad, J. S., & Pashaiasl, M. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.063 · Cited by 25 · see citing works

[Epithelial-mesenchymal Transition: Biological Basis and Clinical Prospects of Lung Cancer Invasion, Metastasis, and Drug Resistance].

Sun, H., Xiong, M., Xie, S., & Wen, J. (2025) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2025.102.07 · Cited by 2 · see citing works

Epithelial mesenchymal transition and lung cancer.

Xiao, D., & He, J. (2010) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2010.02.03.7 · Cited by 193 · see citing works

Epithelial Mesenchymal Transition in Aggressive Lung Cancers

Mittal, V. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2_3 · Cited by 91 · see citing works

Epithelial-to-Mesenchymal Transition: Liaison between Cancer Metastasis and Drug Resistance

Du, F., Liu, H., Lu, Y., Zhao, X., & Fan, D. (2017) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2018024855 · Cited by 25 · see citing works

Epithelial to mesenchymal transition: The doorway to metastasis in human lung cancers

Denlinger, C. E., Ikonomidis, J. S., Reed, C. E., & Spinale, F. G. (2010) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.02.061 · Cited by 42 · see citing works